Active Fine Chemicals Past Earnings Performance
Past criteria checks 0/6
Active Fine Chemicals's earnings have been declining at an average annual rate of -108.3%, while the Pharmaceuticals industry saw earnings growing at 11% annually. Revenues have been declining at an average rate of 20.4% per year.
Key information
-108.3%
Earnings growth rate
-108.6%
EPS growth rate
| Pharmaceuticals Industry Growth | 11.0% |
| Revenue growth rate | -20.4% |
| Return on equity | -0.09% |
| Net Margin | -0.3% |
| Last Earnings Update | 31 Mar 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Active Fine Chemicals makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 23 | 1,352 | -5 | 166 | 0 |
| 31 Dec 22 | 1,443 | 1 | 179 | 0 |
| 30 Sep 22 | 1,523 | -25 | 191 | 0 |
| 30 Jun 22 | 1,672 | 26 | 261 | 0 |
| 31 Mar 22 | 1,699 | 55 | 293 | 0 |
| 31 Dec 21 | 1,828 | 53 | 305 | 0 |
| 30 Sep 21 | 1,853 | 94 | 305 | 0 |
| 30 Jun 21 | 1,821 | 38 | 247 | 0 |
| 31 Mar 21 | 1,383 | -245 | 207 | 0 |
| 31 Dec 20 | 1,201 | -206 | 198 | 0 |
| 30 Sep 20 | 1,206 | -157 | 194 | 0 |
| 30 Jun 20 | 1,308 | -56 | 195 | 0 |
| 31 Mar 20 | 1,776 | 377 | 215 | 0 |
| 31 Dec 19 | 2,115 | 541 | 223 | 0 |
| 30 Sep 19 | 2,346 | 671 | 226 | 0 |
| 30 Jun 19 | 2,419 | 712 | 228 | 0 |
| 31 Mar 19 | 2,308 | 989 | 216 | 0 |
| 31 Dec 18 | 2,224 | 915 | 207 | 0 |
| 30 Sep 18 | 2,173 | 846 | 207 | 0 |
| 30 Jun 18 | 2,156 | 825 | 200 | 0 |
| 31 Mar 18 | 2,272 | 548 | 201 | 0 |
| 31 Dec 17 | 2,225 | 556 | 194 | 0 |
| 30 Sep 17 | 2,179 | 558 | 181 | 0 |
| 30 Jun 17 | 2,129 | 554 | 170 | 0 |
| 31 Mar 17 | 1,896 | 486 | 141 | 0 |
| 31 Dec 16 | 1,837 | 459 | 131 | 0 |
| 30 Sep 16 | 1,810 | 457 | 125 | 0 |
| 30 Jun 16 | 1,894 | 481 | 133 | 0 |
| 30 Sep 15 | 1,665 | 457 | 105 | 0 |
| 30 Jun 15 | 1,539 | 420 | 100 | 0 |
| 31 Mar 15 | 1,460 | 383 | 98 | 0 |
| 31 Dec 14 | 1,395 | 359 | 91 | 0 |
| 30 Sep 13 | 1,223 | 336 | 109 | 0 |
| 30 Jun 13 | 1,066 | 306 | 99 | 0 |
Quality Earnings: ACTIVEFINE is currently unprofitable.
Growing Profit Margin: ACTIVEFINE is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if ACTIVEFINE's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare ACTIVEFINE's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ACTIVEFINE is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-2.6%).
Return on Equity
High ROE: ACTIVEFINE has a negative Return on Equity (-0.085%), as it is currently unprofitable.